Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Astellas signs stem cell partnership in liver disease

December 8, 2010 Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine

Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …
News

Out-of-hour procedures for clinical trials

December 8, 2010 Research and Development GCP, Good Clinical Practice, Guy’s and St Thomas’ NHS Foundation Trust, Katherine Kennedy, clinical trials, trial safety

When a clinical trial subject is involved in a medical emergency, the hospital team need rapid access to information about …
Feature

Contract research news in brief

December 8, 2010 Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations

Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …
News

Trial hitch for Pfizer’s leukaemia drug submission plans

December 7, 2010 Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia

Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …
News

Roche’s MabThera successor shows phase II promise

December 6, 2010 Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia

The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
News

Surprise exit for Pfizer chief executive Jeffrey Kindler

December 6, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession

Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
News

Apitope appoints Hayley French

December 6, 2010 Research and Development, Sales and Marketing Apitope, Hayley French, appointment, research and development, sales and marketing

Belgium-based biopharmaceutical company Apitope has appointed Hayley French to its management team as commercial director. She will be responsible for …
Appointment

Caligor Rx strengthens its European Team

December 3, 2010 Research and Development Caligor Rx, Jacquelyn May, Jess McKenna, appointment, research and development

Clinical trial procurement firm Caligor Rx has appointed Jess McKenna head of quality assurance and customer relationships and Jacquelyn May …
Appointment

Merck acquires innovative insulin firm SmartCells

December 3, 2010 Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin

Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …
News

Tolerx to collaborate on first-in-class cancer antibody

December 2, 2010 Research and Development Cancer, T cell, Torelx, monoclonal antibody

US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
News

EMA to widen public access to documents

December 1, 2010 Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency

The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …
News

New chief executive for Merck & Co

December 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough

Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
News

Dr Martino Picardo to lead Stevenage Bioscience Catalyst

December 1, 2010 Research and Development Dr Martino Pacardo, Stevenage Bioscience Catalyst, appointment, research and development

New UK science park Stevenage Bioscience Catalyst (SBC) has appointed Dr Martino Picardo as its first chief executive. Dr Picardo …
Appointment

UK pharma welcomes government reforms

November 30, 2010 Manufacturing and Production, Research and Development, Sales and Marketing ABHI, ABPI, BIA, R&D tax credits, UK pharma, patent box

The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …
News

Penn Pharma appoints new chief executive

November 30, 2010 Manufacturing and Production, Research and Development David Cooper, Penn Pharma, Richard Yarwood, appointment, manufacturing and production, research and development

Richard Yarwood has joined pharmaceutical services provider Penn Pharma as chief executive. He has more than 33 years experience in …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026